Department of Biotechnology, Armauer Hansen Research Institute, Ethiopia
Perspective
High Antibody Response for SARS-Cov-2 Infected Individuals by ChAdOx1 nCoV-19 Vaccine
Author(s): Tesfaye Gelanew*